Cited by — Abstract No: 168 A PHASE 2 RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL TRIAL OF MIL116, A NOVEL 'SWEEPER' ANTI-APRIL MONOCLONAL ANTIBODY, IN PARTICIPANTS WITH IMMUNOGLOBULIN A NEPHROPATHY | ResearchHub - ResearchHub
Research graph
Cited by
Admitted local publications that cite Abstract No: 168 A PHASE 2 RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL TRIAL OF MIL116, A NOVEL 'SWEEPER' ANTI-APRIL MONOCLONAL ANTIBODY, IN PARTICIPANTS WITH IMMUNOGLOBULIN A NEPHROPATHY.
No admitted local citation edges point to this work yet.
